These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1684814)
21. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors. Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236 [TBL] [Abstract][Full Text] [Related]
22. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. Bockman CS; Jeffries WB; Abel PW J Pharmacol Exp Ther; 1993 Dec; 267(3):1126-33. PubMed ID: 7903385 [TBL] [Abstract][Full Text] [Related]
23. Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes. Deupree JD; Hinton KA; Cerutis DR; Bylund DB J Pharmacol Exp Ther; 1996 Sep; 278(3):1215-27. PubMed ID: 8819505 [TBL] [Abstract][Full Text] [Related]
24. Characterization of subtypes of alpha-2 adrenoceptors in the human brain. Ordway GA; Jaconetta SM; Halaris AE J Pharmacol Exp Ther; 1993 Feb; 264(2):967-76. PubMed ID: 8382286 [TBL] [Abstract][Full Text] [Related]
25. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes. Renouard A; Widdowson PS; Millan MJ J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207 [TBL] [Abstract][Full Text] [Related]
26. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304. Galitzky J; Lafontan M; Paris H; Berlan M J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682 [TBL] [Abstract][Full Text] [Related]
27. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists. Galitzky J; Mauriege P; Berlan M; Lafontan M J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681 [TBL] [Abstract][Full Text] [Related]
28. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Neubig RR; Gantzos RD; Brasier RS Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672 [TBL] [Abstract][Full Text] [Related]
29. Potent alpha(2A)-adrenoceptor-mediated vasoconstriction by brimonidine in porcine ciliary arteries. Wikberg-Matsson A; Simonsen U Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2049-55. PubMed ID: 11481271 [TBL] [Abstract][Full Text] [Related]
30. Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype. MacLennan SJ; Luong LA; Jasper JR; To ZP; Eglen RM Br J Pharmacol; 1997 Aug; 121(8):1721-9. PubMed ID: 9283709 [TBL] [Abstract][Full Text] [Related]
31. In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29. Paris H; Taouis M; Galitzky J Mol Pharmacol; 1987 Nov; 32(5):646-54. PubMed ID: 2891026 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig. Uhlén S; Muceniece R; Rangel N; Tiger G; Wikberg JE Pharmacol Toxicol; 1995 Jun; 76(6):353-64. PubMed ID: 7479575 [TBL] [Abstract][Full Text] [Related]
34. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Turner JT; Ray-Prenger C; Bylund DB Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. Blaxall HS; Murphy TJ; Baker JC; Ray C; Bylund DB J Pharmacol Exp Ther; 1991 Oct; 259(1):323-9. PubMed ID: 1656026 [TBL] [Abstract][Full Text] [Related]
36. Heterologous expression of the cloned guinea pig alpha 2A, alpha 2B, and alpha 2C adrenoceptor subtypes. Radioligand binding and functional coupling to a CAMP-responsive reporter gene. Svensson SP; Bailey TJ; Porter AC; Richman JG; Regan JW Biochem Pharmacol; 1996 Feb; 51(3):291-300. PubMed ID: 8573196 [TBL] [Abstract][Full Text] [Related]
37. Peripheral nociceptive effects of alpha 2-adrenergic receptor agonists in the rat. Khasar SG; Green PG; Chou B; Levine JD Neuroscience; 1995 May; 66(2):427-32. PubMed ID: 7477883 [TBL] [Abstract][Full Text] [Related]
38. 3H-atipamezole binding sites in mouse cerebral cortex: possible involvement of alpha 2-adrenoceptors in sexual behavior. Rägo L; Saano V; Tupala E; Nieminen SA; Airaksinen MM Methods Find Exp Clin Pharmacol; 1992; 14(1):23-7. PubMed ID: 1352369 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Bylund DB; Blaxall HS; Iversen LJ; Caron MG; Lefkowitz RJ; Lomasney JW Mol Pharmacol; 1992 Jul; 42(1):1-5. PubMed ID: 1353247 [TBL] [Abstract][Full Text] [Related]
40. The alpha 2-adrenoceptors of the human retinoblastoma cell line (Y79) may represent an additional example of the alpha 2C-adrenoceptor. Gleason MM; Hieble JP Br J Pharmacol; 1992 Sep; 107(1):222-5. PubMed ID: 1358385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]